The Population Health Research Institute, McMaster University and Hamilton Health Sciences, and the Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Institute of Health Informatics, University College London, London, United Kingdom.
Can J Cardiol. 2021 Jul;37(7):1112-1116. doi: 10.1016/j.cjca.2021.04.012. Epub 2021 Apr 29.
The supply limitations of COVID-19 vaccines have led to the need to prioritize vaccine distribution. Obesity, diabetes, and hypertension have been associated with an increased risk of severe COVID-19 infection. Approximately half as many individuals with a cardiovascular risk factor need to be vaccinated against COVID-19 to prevent related death compared with individuals without a risk factor. Adults with body mass index ≥ 30, diabetes, or hypertension should be of a similar priority for COVID-19 vaccination to adults 10 years older with a body mass index of 20 to < 30, no diabetes, and no hypertension.
COVID-19 疫苗的供应限制导致需要优先考虑疫苗的分配。肥胖、糖尿病和高血压与 COVID-19 感染严重程度增加有关。与没有风险因素的个体相比，每有一半的心血管风险因素个体需要接种 COVID-19 疫苗来预防相关死亡。身体质量指数（BMI）≥30、糖尿病或高血压的成年人应该与身体质量指数为 20 至<30、无糖尿病和无高血压且年龄大 10 岁的成年人具有类似的 COVID-19 疫苗接种优先级。
